Cargando…

The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up

PURPOSE: Lung cancer represents the first cause of cancer-related death in the world. Radiomics studies arise rapidly in this late decade. The aim of this review is to identify important recent publications to be synthesized into a comprehensive review of the current status of radiomics in lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: El Ayachy, Radouane, Giraud, Nicolas, Giraud, Paul, Durdux, Catherine, Giraud, Philippe, Burgun, Anita, Bibault, Jean Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131863/
https://www.ncbi.nlm.nih.gov/pubmed/34026602
http://dx.doi.org/10.3389/fonc.2021.603595
_version_ 1783694796248842240
author El Ayachy, Radouane
Giraud, Nicolas
Giraud, Paul
Durdux, Catherine
Giraud, Philippe
Burgun, Anita
Bibault, Jean Emmanuel
author_facet El Ayachy, Radouane
Giraud, Nicolas
Giraud, Paul
Durdux, Catherine
Giraud, Philippe
Burgun, Anita
Bibault, Jean Emmanuel
author_sort El Ayachy, Radouane
collection PubMed
description PURPOSE: Lung cancer represents the first cause of cancer-related death in the world. Radiomics studies arise rapidly in this late decade. The aim of this review is to identify important recent publications to be synthesized into a comprehensive review of the current status of radiomics in lung cancer at each step of the patients’ care. METHODS: A literature review was conducted using PubMed/Medline for search of relevant peer-reviewed publications from January 2012 to June 2020 RESULTS: We identified several studies at each point of patient’s care: detection and classification of lung nodules (n=16), determination of histology and genomic (n=10) and finally treatment outcomes predictions (=23). We reported the methodology of those studies and their results and discuss the limitations and the progress to be made for clinical routine applications. CONCLUSION: Promising perspectives arise from machine learning applications and radiomics based models in lung cancers, yet further data are necessary for their implementation in daily care. Multicentric collaboration and attention to quality and reproductivity of radiomics studies should be further consider.
format Online
Article
Text
id pubmed-8131863
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81318632021-05-20 The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up El Ayachy, Radouane Giraud, Nicolas Giraud, Paul Durdux, Catherine Giraud, Philippe Burgun, Anita Bibault, Jean Emmanuel Front Oncol Oncology PURPOSE: Lung cancer represents the first cause of cancer-related death in the world. Radiomics studies arise rapidly in this late decade. The aim of this review is to identify important recent publications to be synthesized into a comprehensive review of the current status of radiomics in lung cancer at each step of the patients’ care. METHODS: A literature review was conducted using PubMed/Medline for search of relevant peer-reviewed publications from January 2012 to June 2020 RESULTS: We identified several studies at each point of patient’s care: detection and classification of lung nodules (n=16), determination of histology and genomic (n=10) and finally treatment outcomes predictions (=23). We reported the methodology of those studies and their results and discuss the limitations and the progress to be made for clinical routine applications. CONCLUSION: Promising perspectives arise from machine learning applications and radiomics based models in lung cancers, yet further data are necessary for their implementation in daily care. Multicentric collaboration and attention to quality and reproductivity of radiomics studies should be further consider. Frontiers Media S.A. 2021-05-05 /pmc/articles/PMC8131863/ /pubmed/34026602 http://dx.doi.org/10.3389/fonc.2021.603595 Text en Copyright © 2021 El Ayachy, Giraud, Giraud, Durdux, Giraud, Burgun and Bibault https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
El Ayachy, Radouane
Giraud, Nicolas
Giraud, Paul
Durdux, Catherine
Giraud, Philippe
Burgun, Anita
Bibault, Jean Emmanuel
The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up
title The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up
title_full The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up
title_fullStr The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up
title_full_unstemmed The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up
title_short The Role of Radiomics in Lung Cancer: From Screening to Treatment and Follow-Up
title_sort role of radiomics in lung cancer: from screening to treatment and follow-up
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131863/
https://www.ncbi.nlm.nih.gov/pubmed/34026602
http://dx.doi.org/10.3389/fonc.2021.603595
work_keys_str_mv AT elayachyradouane theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT giraudnicolas theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT giraudpaul theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT durduxcatherine theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT giraudphilippe theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT burgunanita theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT bibaultjeanemmanuel theroleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT elayachyradouane roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT giraudnicolas roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT giraudpaul roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT durduxcatherine roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT giraudphilippe roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT burgunanita roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup
AT bibaultjeanemmanuel roleofradiomicsinlungcancerfromscreeningtotreatmentandfollowup